PhaseBio
-
Malvern’s PhaseBio Signs Co-Development Deal with Pharma Firm, Sees Major Bump in Share Price
Malvern’s PhaseBio saw its shares soar after it signed a financing and co-development deal with California-based SFJ Pharmaceuticals worth up to $120 million, writes Ryan…
-
Investors Bullish on Malvern-Based PhaseBio as Its Stock Nearly Triples in Six Months
PhaseBio, a small biopharmaceuticals firm in Malvern, has seen its stock nearly triple in the last six months following its IPO, writes Joseph DiStefano for…
-
PhaseBio Licenses Drug Delivery Technology to Duke University
PhaseBio Pharmaceuticals has signed a deal with Duke University, giving the university exclusive rights to its drug-delivery technology for use in treating cancer. However, PhaseBio…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
